- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06712992
Electromyographic Response to TsDcs in CNSLBP
Effect of Trans-Spinal Direct Current Stimulation in the Management of Non-Specific Chronic Low Back Pain: a Randomized Controlled Trial
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Giza
-
Sixth of October, Giza, Egypt, 12611
- Outpatient clinic of faculty of physical therapy, Ahram Canadian University
-
sixth of October, Giza, Egypt, 12611
- Outpatient clinical of faculty of physical therapy, Ahram Canadian University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals of both sexes.
- Age 18-60 years old.
- Chronic non-specific low back pain according to the most recent guidelines for the diagnosis and management of NSLPB come from the American College of Physicians and was published in 2017. According to these guidelines, the diagnosis of chronic NSLBP should be made based on the following criteria:
- Chronic low back pain, defined as pain lasting for more than 12 weeks.
- No specific identifiable cause of pain(e.g. infection, malignancy, fracture, inflammatory disorder).
- No radicular symptoms(e.g. pain radiating down the leg).
- No significant neurological deficits or findings on physical examination(e.g. loss of reflexes or muscle strength).
Exclusion Criteria:
- Previous fractures and/or surgery in the vertebral spine.
- Neuropathic pain extending along the lower limb due to nerve root compression.
- History of spine trauma or fracture.
- Implanted pacemakers.
- Pregnancy.
- Malignancy.
- Systemic musculoskeletal diseases.
- Epilepsy.
- History of psychiatric disorders.
- Obesity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Trans-spinal direct current stimulation group
Patients in this group will receive Conventional Exercises in addition to tsDCS.
We will apply a current density of 0.035 mA/cm2 and will deliver a total charge density of 42.8 mC/cm2, below the threshold values reported for tissue damage.
For tsDcs, At the onset of tsDCS, the current will be increased for 30 s, and at the offset, it will be decreased for 30 s in a ramp-like manner.
Participants will receive three sessions of treatment per week for four weeks, with a total of twelve sessions.
|
Physiomed- IONOSON-Expert, Germany will be used to deliver SHAM direct current, The Physiomed- IONOSON-Expert, Germany is Two-channel electrotherapy including 21 currents, including direct current.
The tsDCS electrodes will be rectangular pieces of saline-soaked synthetic sponge (7 × 8 cm, 56 cm2), to minimize chemical reactions at the electrode-skin interface.
The anode will be placed over the spinous process of the eighth thoracic vertebra (T8) and the cathode will be placed on the second lumbar vertebra (L2) according to a modeling study which demonstrated that this configuration had a relevant impact on the distribution of the induced electric field (EF) in the lumbosacral spinal cord for the efficacy of tsDCS.
|
|
Sham Comparator: Sham Trans-spinal direct current stimulation group
Patients in this group will receive Conventional Exercises in addition to SHAM tsDCS.
For a sham tsDCS, the current will be ramped up for 30 seconds turned on for 5 s and then turned off in a ramp shaped fashion, thus inducing skin sensations indistinguishable from anodal tsDCS.
This method was shown to achieve a good level of blinding among sessions.
Participants will receive three sessions of treatment per week for four weeks, with a total of twelve sessions.
|
For a sham tsDCS, the current will be ramped up for 30 seconds turned on for 5 s and then turned off in a ramp shaped fashion, thus inducing skin sensations indistinguishable from anodal tsDCS. This method was shown to achieve a good level of blinding among sessions. These parameters for sham stimulation were chosen based on previous reports that the perceived sensations on the skin, such as tingling, fade usually out in the first 30 s of TsDcs . |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in NPRS from baseline to four weeks
Time Frame: Baseline and 4 weeks
|
An 11-point Numerical Pain Rating Scale (NPRS; 0= no pain, 10= maximum pain) will be used to assess the patients' pre and post treatment levels of back pain.
The NPRS can be administered verbally (therefore also by telephone) or graphically for self-completion.
Scores range from 0-10 points, with higher scores indicating greater pain intensity
|
Baseline and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Nociceptive Flexion Reflex (NFR) Threshold and area from baseline to 4 weeks
Time Frame: Baseline and 4 weeks
|
The NFR threshold will be assessed as an objective measure of spinal nociceptive processing in adults with chronic non-specific low back pain (CNSLBP).
The NFR threshold will be defined as the lowest stimulus intensity that elicits an NFR response.The NFR threshold and NFR area will be assessed before and after 4 weeks of trans-spinal direct current stimulation (tsDCS) plus exercise or sham stimulation plus exercise.
|
Baseline and 4 weeks
|
|
Changes in PROMIS Global Health - 10 Survey from baseline to 4 weeks
Time Frame: Baseline and 4 weeks
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) is a comprehensive instrument designed to assess health-related quality of life across various domains.
PROMIS GH-10, specifically, is tailored to measure global physical and mental health.
It encompasses a range of items that evaluate general health perceptions, physical function, pain, fatigue, emotional distress, and social health.
PROMIS GH-10 has been demonstrated to be reliable and valid for use in the general population and various specific conditions, such as low back pain.
|
Baseline and 4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T/REC/2024.10021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
University of Kansas Medical CenterCompletedLower Back Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Postural Low Back Pain | Mechanical Low Back Pain | Low Back Ache | Recurrent Low Back Pain | Lower Back Pain Chronic | Low Back Pain, Posterior Compartment | Low BackacheUnited States
-
Istanbul UniversityIstinye UniversityCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, PosturalTurkey
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
General Incorporated Foundation Ryukyuseimeisaiseikai...CompletedChronic Low Back Pain | Non-specific Low Back Pain | Low Back Pain (LBP)Japan
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Ache Laboratorios Farmaceuticos S.A.Unknown
Clinical Trials on Trans-spinal Direct Current Stimulation
-
Northwell HealthPathMaker Neurosystems Inc.; Dr. Zaghloul AhmedCompletedStroke | Muscle Spasticity | Hemiparesis | Upper Extremity Paralysis | Spasticity as Sequela of Stroke | Cerebrovascular Accident (CVA)United States
-
Universidade Federal de PernambucoEnrolling by invitation
-
Baylor College of MedicineBrain & Behavior Research FoundationTerminatedSchizophrenia | PsychosisUnited States
-
University of Texas Southwestern Medical CenterRecruitingAnorexia NervosaUnited States
-
Centre Hospitalier St AnneNot yet recruitingSexual Addiction | Hypersexualism
-
Universidade Federal de PernambucoRecruiting
-
Universidade Federal de PernambucoActive, not recruitingAtaxia, CerebellarBrazil
-
University of CincinnatiLindner Center of HOPE; Brain & Behavior Research FoundationCompletedMajor Depressive DisorderUnited States
-
Dina Hatem ElhammadyUnknown
-
Bronx VA Medical CenterNew York State Department of HealthCompletedSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Tetraplegia/TetraparesisUnited States